CMR Short Reviews
- The Concept of CMR
  Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.
- Evaluating CMR
  Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).
- Managing CMR
  Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.
Documentation Centre
- Slides, videos and more

Documentation Centre

August 01, 2012: How do you foresee the pharmacological management of cardiovascular risk in the near future?; By H. Bryan Brewer, Jr., MD, Director, Washington Cardiovascular Associates, Senior Research Consultant, Cardiovascular Research Institute, Washington Hospital Center, Washington, D.C., USA [1:00 min.] [4MB]

See all Expert Opinions of H. Bryan Brewer, Jr., MD, Director, Washington Cardiovascular Associates, Senior Research Consultant, Cardiovascular Research Institute, Washington Hospital Center, Washington, D.C., USA

Key Words
Cardiovascular Disease, Lipids/Lipoproteins, Clinical Cardiology

The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.

E-mail address
Confirm E-mail address

Documentation Centre

THANKS FOR DOWNLOADING! WANT MORE?